Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE)
This study is currently recruiting participants.
Study NCT00456508.   Last updated on January 7, 2009.
Information provided by Dyax Corporation
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hereditary Angioedema
Additional conditions recognized in this trial
Angioedema
Angioedema, Hereditary
More general conditions related to this trial
Cardiovascular Diseases
Genetic Diseases, Inborn
Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Skin Diseases
Skin Diseases, Vascular
Urticaria
Vascular Diseases
Interventions listed in this trial
ecallantide
Sponsors listed in this trial
Dyax Corporation


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services